The wellness world is eager for RFK Jr.'s promised move on peptides

NPR's Will Stone reports on a substantive health policy development with solid sourcing credentials — NPR maintains strong editorial standards and Stone is a named health reporter. The framing is measured, acknowledging both industry enthusiasm and the legitimate regulatory concern (lack of clinical data) in balanced language. The article appears to contextualize the policy shift without inflammatory framing, though readers should note the description's focus on "exploded in popularity" may warrant scrutiny of whether this reflects actual medical benefit or market hype — a critical distinction the article should address given the emphasis on absent data.